Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Titel:
Senolytics decrease senescent cells in humans: Preliminary report from a clinical trial of Dasatinib plus Quercetin in individuals with diabetic kidney disease
Auteur:
Hickson, LaTonya J. Langhi Prata, Larissa G.P. Bobart, Shane A. Evans, Tamara K. Giorgadze, Nino Hashmi, Shahrukh K. Herrmann, Sandra M. Jensen, Michael D. Jia, Qingyi Jordan, Kyra L. Kellogg, Todd A. Khosla, Sundeep Koerber, Daniel M. Lagnado, Anthony B. Lawson, Donna K. LeBrasseur, Nathan K. Lerman, Lilach O. McDonald, Kathleen M. McKenzie, Travis J. Passos, João F. Pignolo, Robert J. Pirtskhalava, Tamar Saadiq, Ishran M. Schaefer, Kalli K. Textor, Stephen C. Victorelli, Stella G. Volkman, Tammie L. Xue, Ailing Wentworth, Mark A. Wissler Gerdes, Erin O. Zhu, Yi Tchkonia, Tamara Kirkland, James L.